A study to evaluate individual patient factors as a predisposition to hepatotoxicity in metastatic renal cell carcinoma patients treated with pazopanib
Latest Information Update: 04 Apr 2016
At a glance
- Drugs Pazopanib (Primary)
- Indications Renal cell carcinoma
- Focus Pharmacodynamics
- 04 Apr 2016 New trial record